Category: ACN Newswire

Hua Medicine Announces 2024 Interim Results

– Dorzagliatin (trade name: HuaTangNing, world’s first dual-acting glucokinase activator (GKA), successfully entered China’s National Reimbursement Drug List for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance (the “NRDL”) at the end of 2023. Hua Medicine worked with sales

More

SmartHK Nanjing concludes

–  Some 40 leaders of business and academia explored Hong Kong-Jiangsu collaboration in finance, I&T, sustainable development, culture and creativity –  Exhibition showcased Hong Kong’s professional services, creative designs and I&T projects. Some 400 business matching meetings were facilitated – 

More